Thank you.
Now, on the Food and Drugs Act, in division 31, under section 30, it is proposed to make three changes to give the Minister of Health quite sweeping powers to make changes to therapeutic products that are used off label in one case, and in the second, that may be intended to be used for animals but are being used for human beings, and to provide an exemption from the act as well.
Could you give us a concrete example of what these proposed sections are targeting?